Cancer Biology and Senescence Biology, Unified

Cancer is uncontrolled cell proliferation. Senescence is failed cell death. They are biological mirror images. Treating them as two unrelated fields, as oncology and gerontology have done for decades, leaves enormous combinatorial therapeutic opportunity unexploited. The CureForge Oncology & Senescence Convergence Institute closes that gap. Twelve specialized AI systems collaborate across combination senolytic-and-checkpoint-inhibitor design, partial-reprogramming-andchemotherapy combinations, hallmark-of-aging targeting in cancer therapy, tumor- suppressor restoration including p53 and retinoblastoma pathway, chimeric-antigenreceptor and T-cell-receptor optimization, tumor microenvironment modeling, bispecific antibody design, antibody-drug conjugate design, cancer vaccine antigen design, liquid biopsy cancer detection, age-stratified cancer cohort analysis, and pediatric cancer specialization coordinated with the rare-disease and developmental-origins institutes.

Value proposition:

• Cancer and senescence as one unified research engine
• Combination senolytic-and-checkpoint-inhibitor design as default rigor
• Age-stratified cancer cohort analysis across the federation